SOLO – Microbiome

Understand and assess the role or microbiome in drug discovery

 A new service offering dedicated to the evaluation of the influence and shaping of the microbiome in the preclinical efficacy of immunotherapies applied in oncology, immuno-oncology and inflammation.

SOLO-Microbiome

  • Ability to mimic the microbial imbalance or dysbiosis observed in diseases such as cancer, gastrointestinal and dermal inflammation, and metabolic disorders
  • A guide of choice in your research programs and new therapies based on microbial agents aiming to modulate the microbiota and immune response
  • Study of the impact of the microbiome in the metabolism of therapeutic products
Microbiome-schéma-EN2-700
Oncodesign
  • Access to specific capabilities and analyses
    • Culture and preparation of aerobic and anaerobic bacteria
    • Bacterial Detection and identification, localization by imaging in animals
    • Transfer of human or animal fecal matter (FMT)
    • Global analysis of the microbiome

Fix a meeting